Eledon Pharmaceuticals (ELDN) EPS (Basic) (2016 - 2017)
Historic EPS (Basic) for Eledon Pharmaceuticals (ELDN) over the last 5 years, with Q1 2017 value amounting to -$9.35.
- Eledon Pharmaceuticals' EPS (Basic) fell 173262.83% to -$9.35 in Q1 2017 from the same period last year, while for Sep 2017 it was -$1.1, marking a year-over-year increase of 9980.31%. This contributed to the annual value of -$36.61 for FY2024, which is 8236.34% up from last year.
- Per Eledon Pharmaceuticals' latest filing, its EPS (Basic) stood at -$9.35 for Q1 2017, which was down 173262.83% from -$9.76 recorded in Q4 2016.
- Over the past 5 years, Eledon Pharmaceuticals' EPS (Basic) peaked at -$0.4 during Q2 2015, and registered a low of -$173.73 during Q2 2016.
- Over the past 5 years, Eledon Pharmaceuticals' median EPS (Basic) value was -$6.03 (recorded in 2017), while the average stood at -$24.84.
- Its EPS (Basic) has fluctuated over the past 5 years, first surged by 9657.53% in 2015, then crashed by 4333274.76% in 2016.
- Quarter analysis of 5 years shows Eledon Pharmaceuticals' EPS (Basic) stood at -$13.32 in 2013, then skyrocketed by 92.79% to -$0.96 in 2014, then surged by 48.94% to -$0.49 in 2015, then tumbled by 1892.64% to -$9.76 in 2016, then rose by 4.27% to -$9.35 in 2017.
- Its EPS (Basic) was -$9.35 in Q1 2017, compared to -$9.76 in Q4 2016 and -$113.97 in Q3 2016.